Kai Laustiola
University of Tampere
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kai Laustiola.
European Journal of Applied Physiology | 1989
Katriina Kukkonen-Harjula; Pekka Oja; Kai Laustiola; Ilkka Vuori; Jukka Jolkkonen; Simo Siitonen; H. Vapaatalo
SummaryEight healthy young men were studied during three periods of heat exposure in a Finnish sauna bath: at 80° C dry bulb (80 D) and 100° C dry bulb (100 D) temperatures until subjective discomfort, and in 80° C dry heat, becoming humid (80 DH) until subjective exhaustion. Oral temperature increased 1.1° C at 80 D, 1.9° C at 100 D and 3.2° C at 80 DH. Heart rate increased about 60% at 80 D, 90% at 100 D and 130% at 80 DH. Plasma noradrenaline increased about 100% at 80 D, 160% at 100 D and 310% at 80 DH. Adrenaline did not change. Plasma prolactin increased 2-fold at 80 D, 7-fold at 100 D and 10-fold at 80 DH. Blood concentrations of the beta-endorphin immunoreactivity at 100 D, adrenocorticotropic hormone (ACTH) at 100 D and 80 DH, growth hormone at 100 D and testosterone at 80 DH also increased, but cortisol at 80 D and 100 D decreased. The plasma prostaglandin E2 and serum thromboxane B2 levels did not change. Patterns related to heat exposure were observed for heart rate, plasma noradrenaline, ACTH and prolactin in the three study periods.
Journal of Cardiovascular Pharmacology | 1991
Kai Laustiola; Mervi Kotamäki; Riitta Lassila; Olli-Pekka Kallioniemi; Vesa Manninen
We report the effects of monitored smoking cessation on adrenergic regulation in chronic smokers. The α2 adrenoceptor density of mononuclear leukocytes (MNLs) and plasma catecholamines was analyzed before cessation and 2.3, and 8 weeks after cessation. We found a progressive increase in α-adrenoceptor density after smoking cessatin. During smoking the α-adrenoceptor density after smoking was 1,456
Journal of Cardiovascular Pharmacology | 1984
Kai Laustiola; Erkki Seppälä; Tapio Nikkari; Heikki Vapaatalo
British Journal of Pharmacology | 1992
Pauli Vuorinen; Ilkka Pörsti; Timo Metsä-Ketelä; Vesa Manninen; H. Vapaatalo; Kai Laustiola
83 (mean
Clinical Pharmacology & Therapeutics | 1988
Kai Laustiola; Riitta Lassila; Anna-Kaisa Nurmi
European Journal of Clinical Pharmacology | 1983
Kai Laustiola; A. Uusitalo; T. Koivula; A. Sovijärvi; Erkki Seppälä; Tapio Nikkari; H. Vapaatalo
SEM) bindings sites per cell (n = 10), whereas 3 weeks after cessation the the density was 1,774
European Journal of Pharmacology | 1983
Kai Laustiola; Pauli Vuorinen; Hekki Vapaatalo; Timo Metsä-Ketelä
Journal of Internal Medicine | 1996
Mervi Kotamäki; Kai Laustiola; Mikko Syvänne; Juhani Heikkilä
157 sites per cell (n = 10: < 0.05), and at 8 weeks, 1,900
Life Sciences | 1984
Pauli Vuorinen; Kai Laustiola; Timo Metsä-Ketelä
European Journal of Clinical Pharmacology | 1993
M. Kotamäki; Vesa Manninen; Kai Laustiola
227 sites per cell in (n = 8; p < 0.05), representing an overall increase of 23% Smoking cessation had no effect on binding affinity nor on lymphocyte subgroup distribution. The density of MNL cell β-adrenoceptors in age-matched nonsmoking men was higher, at 1,896